UNSPSC 51313709: Ketotifen fumarate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H19NOS.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HBD503WORO, chemically known as 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-10h-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one but more generally known as ketotifen fumarate, which bears US NIH Compound Identifier 3827. European Medicines Agency schedules Ketotifen fumarate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02836MIG.

UNSPSC 51313709 Ketotifen fumarate is a Commodity code for a specific pharmaceutical product, but recent state and local solicitation activity under this code shows a significant scope mismatch. The single recent opportunity posted by Seminole County, Florida (IFB 60459723LAS, due July 26, 2023) does not solicit ketotifen fumarate; instead, it seeks naloxone and drug deactivation systems for community health initiatives—pharmaceutical products entirely unrelated to the code's nominal scope. The source provides no evidence of state or local governments actually procuring ketotifen fumarate through recent RFPs, RFQs, IBFs, or ITBs.

The code shows little relevant recent activity. Seminole County's naloxone procurement is structurally typical of state and local pharmaceutical and medical-supply contracting—a competitive bidding process with quarterly deliveries, electronic submission requirements, E-Verify and drug-free workplace compliance, and a two-year term with renewal option—but it does not represent buying under UNSPSC 51313709. Without additional opportunities under the code, no characterization of issuing-body types, geographic concentration, or representative work can be drawn. Business development professionals should verify whether ketotifen fumarate demand exists in their target jurisdictions and whether those buyers are actually tagging relevant solicitations with this commodity code.